当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析 - 现金流量表

山东药玻

(600529)

  

流通市值:122.30亿  总市值:122.30亿
流通股本:6.64亿   总股本:6.64亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,402,167,966.031,139,397,765.114,490,886,217.833,978,406,212.71
  收到的税费返还146,060.71140,883.9729,831,962.5230,073,176.54
  收到其他与经营活动有关的现金16,300,369.375,351,512.8734,545,180.320,695,673.78
  经营活动现金流入小计2,418,614,396.111,144,890,161.954,555,263,360.654,029,175,063.03
  购买商品、接受劳务支付的现金1,328,682,604.44608,617,445.542,642,662,182.712,555,957,541.18
  支付给职工以及为职工支付的现金407,605,746.27222,736,160.18832,623,235.74607,553,128.39
  支付的各项税费221,175,687.4877,251,624.03315,561,608.8235,697,495.85
  支付其他与经营活动有关的现金60,298,287.7623,295,480.98187,491,370.04119,010,369.39
  经营活动现金流出小计2,017,762,325.95931,900,710.733,978,338,397.293,518,218,534.81
  经营活动产生的现金流量净额400,852,070.16212,989,451.22576,924,963.36510,956,528.22
二、投资活动产生的现金流量:
  收回投资收到的现金3,490,000,0002,290,000,0007,990,000,0006,130,000,000
  取得投资收益收到的现金13,021,521.935,914,095.8430,074,799.5624,510,053.34
  处置固定资产、无形资产和其他长期资产收回的现金净额5,243,080.7276,2103,197,307.22,188,587.2
  投资活动现金流入小计3,508,264,602.652,295,990,305.848,023,272,106.766,156,698,640.54
  购建固定资产、无形资产和其他长期资产支付的现金257,408,071.62211,041,960.34231,864,537.19385,042,423.88
  投资支付的现金2,320,000,000820,000,0007,940,000,0006,130,000,000
  投资活动现金流出小计2,577,408,071.621,031,041,960.348,171,864,537.196,515,042,423.88
  投资活动产生的现金流量净额930,856,531.031,264,948,345.5-148,592,430.43-358,343,783.34
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金96,161,963.94-370,341,793.4370,341,793.4
  支付其他与筹资活动有关的现金8,181,341.592,079,383.316,408,210.17-
  筹资活动现金流出小计104,343,305.532,079,383.31376,750,003.57370,341,793.4
  筹资活动产生的现金流量净额-104,343,305.53-2,079,383.31-376,750,003.57-370,341,793.4
四、汇率变动对现金及现金等价物的影响-11,298,295.81-5,991,709.375,793,613.617,322,055.64
五、现金及现金等价物净增加额1,216,066,999.851,469,866,704.0457,376,142.97-210,406,992.88
  加:期初现金及现金等价物余额942,557,504.68942,557,504.68885,181,361.71885,181,361.71
  期末现金及现金等价物余额2,158,624,504.532,412,424,208.72942,557,504.68674,774,368.83
补充资料:
  净利润370,867,951.66-689,626,040.66-
  资产减值准备33,853,345.47-156,894,172.13-
  固定资产和投资性房地产折旧185,607,319.86-382,906,229.57-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧185,607,319.86-382,906,229.57-
  无形资产摊销3,424,010.78-6,763,498.71-
  处置固定资产、无形资产和其他长期资产的损失-2,495,584.87--1,452,467.75-
  固定资产报废损失3,136,134.53-5,756,957.92-
  公允价值变动损失-4,381,715.52--9,136,242.46-
  财务费用11,878,434.33--5,304,673.54-
  投资损失-9,582,895.86--17,548,332.44-
  递延所得税-1,093,568.64--17,331,349.14-
  其中:递延所得税资产减少-1,093,568.64--17,331,349.14-
  存货的减少-72,485,409.59--520,117,827.63-
  经营性应收项目的减少-46,941,543.83-299,248,910.05-
  经营性应付项目的增加-80,718,835.44--390,259,010.65-
  其他-441,922.14--4,585,106.93-
  不涉及现金收支的投资和筹资活动金额其他项目--43,422,548.42-
  现金的期末余额2,158,624,504.53-942,557,504.68-
  减:现金的期初余额942,557,504.68-885,181,361.71-
  现金及现金等价物的净增加额1,216,066,999.85-57,376,142.97-
公告日期2026-08-252026-04-252026-03-072025-10-28
审计意见(境内)标准无保留意见
TOP↑